Compare Moderna, Inc. (MRNA) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs 22nd Century Group Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Moderna, Inc. is far larger — about 15838.9× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| MRNA | XXII | |
|---|---|---|
Market Cap | $23.60B | $1.49M |
Sector | Health | Technology |
52-Week High | $81.80 | $1.07K |
52-Week Low | $22.36 | $3.90 |
Enterprise Value | $19.70B | -$6.74M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
